Oral Activated Charcoal Adsorbent (AST-120) Ameliorates Chronic Kidney Disease-Induced Intestinal Epithelial Barrier Disruption
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Background: Chronic kidney disease (CKD) impairs intestinal barrier function which by allowing influx of noxious products causes systemic inflammation. We have recently shown that intestinal barrier dysfunction in CKD is due to degradation of epithelial tight junction (TJ) which is, in part, mediated by influx of urea and its conversion to ammonia by microbial urease. We hypothesized that by adsorbing urea and urea-derived ammonia, oral activated charcoal (AST-120) may ameliorate CKD-induced intestinal epithelial barrier disruption and systemic inflammation. Methods: Rats were randomized to the CKD or control groups. The CKD group was fed a chow containing 0.7% adenine for 2 weeks. They were then randomized to receive a chow with or without AST-120 (4 g/kg/day) for 2 weeks. Rats consuming regular diet served as controls. Animals were then euthanized, colons were removed and processed for Western blot and immunohistology, and plasma was used to measure endotoxin and oxidative and inflammatory markers. Results: Compared with the controls, the untreated CKD rats showed elevated plasma endotoxin, IL-6, TNF-α, MCP-1, CINC-3, L-selectin, ICAM-1, and malondialdehyde, and depletions of colonic epithelial TJ proteins, claudin-1, occludin, and ZO1. Administration of AST-120 resulted in partial restoration of the epithelial TJ proteins and reduction in plasma endotoxin and markers of oxidative stress and inflammation. Conclusions: CKD animals exhibited depletion of the key protein constituents of the colonic epithelial TJ which was associated with systemic inflammation, oxidative stress and endotoxemia. Administration of AST-120 attenuated uremia-induced disruption of colonic epithelial TJ and the associated endotoxemia, oxidative stress and inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intestinal mucosal barrier function in health and disease
Turner, J. R. (2009) · Nature reviews. Immunology · doi:10.1038/nri2653 · Cited by 3,952
Chronic kidney disease alters intestinal microbial flora
Vaziri, N. D., Wong, J., Pahl, M., Piceno, Y. M., Yuan, J., DeSantis, T. Z., Ni, Z., Nguyen, T.-H., & Andersen, G. L. (2013) · Kidney International · doi:10.1038/ki.2012.345 · Cited by 1,164
Self-citationIto, S., Higuchi, Y., Yagi, Y., Nishijima, F., Yamato, H., Ishii, H., Osaka, M., & Yoshida, M. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.0112023 · Cited by 72 · cited 2×
“The salutary effects of AST-120 have been primarily attributed to its ability to limit formation and absorption of indoxyl sulfate and p-cresol sulfate [25,26].”
Background
Cited by
The Gut Microbiome, Kidney Disease, and Targeted Interventions
Ramezani, A., & Raj, D. S. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013080905 · Cited by 743
Wong, J., Piceno, Y. M., DeSantis, T. Z., Pahl, M., Andersen, G. L., & Vaziri, N. D. (2014) · American Journal of Nephrology · doi:10.1159/000360010 · Cited by 638
Self-citationThe Gut as a Source of Inflammation in Chronic Kidney Disease
Lau, W. L., Kalantar-Zadeh, K., & Vaziri, N. D. (2015) · Nephron · doi:10.1159/000381990 · Cited by 461
Self-citationVaziri, N. D., Zhao, Y.-Y., & Pahl, M. V. (2016) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv095 · Cited by 394
Self-citationRole of the Gut Microbiome in Uremia: A Potential Therapeutic Target
Ramezani, A., Massy, Z. A., Meijers, B., Evenepoel, P., Vanholder, R., & Raj, D. S. (2016) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2015.09.027 · Cited by 394
“The primary effect of AST-120 appears to be mediated through its adsorption of urea-derived ammonia and interruption of enterohepatic urea recycling.(147) Although small randomized controlled animal studies have suggested a renoprotective effect for AST-120, a subsequent large randomized controlled trial could not con…”
BackgroundAndersen, K., Kesper, M. S., Marschner, J. A., Konrad, L., Ryu, M., Kumar VR, S., Kulkarni, O. P., Mulay, S. R., Romoli, S., Demleitner, J., et al. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015111285 · Cited by 266
Altered microbiome in chronic kidney disease: systemic effects of gut-derived uremic toxins
Lau, W. L., Savoj, J., Nakata, M. B., & Vaziri, N. D. (2018) · Clinical Science · doi:10.1042/cs20171107 · Cited by 237
Self-citationChronic Kidney Disease Causes Disruption of Gastric and Small Intestinal Epithelial Tight Junction
Vaziri, N. D., Yuan, J., Nazertehrani, S., Ni, Z., & Liu, S. (2013) · American Journal of Nephrology · doi:10.1159/000353764 · Cited by 195
Self-citationGhosh, S. S., Bie, J., Wang, J., & Ghosh, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108577 · Cited by 161
Uremic Toxin-Producing Gut Microbiota in Rats with Chronic Kidney Disease
Kikuchi, M., Ueno, M., Itoh, Y., Suda, W., & Hattori, M. (2017) · Nephron · doi:10.1159/000450619 · Cited by 82
Contribution of gut microbiota toward renal function in sepsis
Xu, Y., Kong, X., Zhu, Y., Xu, J., Mao, H., Li, J., Zhang, J., & Zhu, X. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.985283 · Cited by 22
Metadata
- Authors
- Vaziri, N. D., Yuan, J., Khazaeli, M., Masuda, Y., Ichii, H., & Liu, S.
- Venue
- American Journal of Nephrology
- Publisher
- S. Karger AG
- Published
- 2013
- Volume
- 37
- Issue
- 6
- Pages
- 518-525
- ISSN
- 0250-8095 (ISSN-L)
- 1421-9670
- OpenAlex
- W2135805191
- Cited by
- 103
- References
- 3
- FWCI
- 8.84
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.